Skip to main content
. 2020 Dec 1;9(12):3903. doi: 10.3390/jcm9123903

Table 3.

Comparative table of the Tacro AUC exposure values’ compliance within therapeutic ranges.

Number of Subjects 1–5 Years
(Tacro + MMF)
>5 Years
(Tacro + MMF)
1–5 Years
(Tacro)
>5 Years
(Tacro)
72 44 10 18
Therapeutic range <120 µg/h/L 23 (31.9%) 20 (45.5%) 6 (60.0%) 8 (44.4%)
120–150
µg/h/L
23 (31.9%) 11 (25.0%) 4 (40.0%) 5 (27.8%)
>150 µg/h/L 26 (36.1%) 13 (29.5%) - 5 (27.8%)

MMF—mycophenolate mofetil; Tacro—tacrolimus.